An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (1)
  • Publications (126)
  • Training (0)
  • User case (1)
  • User meeting (0)
  • Webinar (9)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • (-) Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • (-) Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Brain and CNS
  • (-) Genito-urinary

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.

14/05/2023
/ Publications

This study reported outcomes of 194 patients diagnosed with IDH-mutated WHO grade 2 (n = 128) and WHO grade 3 (n = 66) glioma treated with proton radiation...

Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.

14/05/2023
/ Publications
/
Proton therapy center

This study presented results of 52 patients with IDH-mutant diffuse gliomas treated with proton radiation. Tumor classified by WHO grade 2, 3 and 4 were 22, 25...

Comparison of the Effectiveness of Radiotherapy with 3D-CRT, IMRT, VMAT and PT for Newly Diagnosed Glioblastoma: A Bayesian Network Meta-Analysis.

14/12/2023
/ Publications
/
IMRT
VMAT

Based on six original studies including 816 glioblastoma multiforme patients, this comprehensive synthesis of data performed by a Bayesian network meta-analysis...

Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma

14/05/2021
/ Publications
/
Dosimetry

This study included148 chordoma and chondrosarcoma patients and 283 individual eyes with functional vision at baseline who received a minimum 30GyRBE to 0.1cm3...

Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy.

14/09/2021
/ Publications
/
Toxicity

This study reported outcomes of 48 patients with skull base chondrosarcoma who underwent particle therapy (67% PT, 33% CIRT). With a median follow-up of 38...

Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience.

14/03/2023
/ Publications
/
Toxicity

This study reported clinical outcomes of 44 patients treated with proton (89%) or carbon ion therapy (11%). At a median follow-up of 34.3 months, 2-, and 3-year...

Proton versus photon radiation therapy: A clinical review.

16/03/2023
/ Publications
/
Clinical Trial

This review summarized comparative clinical outcomes between proton and photon radiotherapy. 63 interventional comparative studies were presented in this...

Case Study: CNS & Leptomeningeal Disease

22/07/2024
/ Webinar

Case Study on CNS & Leptomeningeal Disease presented by Dr. Minesh Mehta at ISOP 2024.

PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.

30/10/2024
/ Publications

Lower gastrointestinal (LGI) tract malignancies arise from the rectum and anal canal. The PTCOG GI Subcommittee conducted a systematic literature review, and...

Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.

30/10/2024
/ Publications

This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...

Pagination

  • Previous page ‹
    • Page 8
    • Current page 9
    • Page 10
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies